INVA | InnovivaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$20.93
-$0.09 (-0.43%)

Innoviva (INVA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat below the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $20.93 vs 50 $20.99 / 200 $21.90
Projection
No cross projected
Test
No active test
Last cross
Death cross 24 Aug 2026 ยท projected 28 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $21.22 vs 50 $21.60 / 200 $17.58
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 1 Apr 2024 ยท projected 20 bars out

4-hour as of 3 Nov 16:00 ET

Price
below both $20.93 vs 50 $20.99 / 200 $21.39
Projection
No cross projected
Test
No active test
Last cross
Death cross 8 Jun 2026 bar 2 ยท projected 24 bars out ยท tested 3 bars

Cross history

35
crosses on record since 2018
17 golden18 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
24 Aug 2026Death moderatedaily28 bars outNot tested
8 Jun 2026Death4-hour24 bars out3 bar cross test
26 Nov 2025Golden moderatedaily25 bars outNot tested
19 Nov 2025Golden4-hour26 bars outNot tested
29 Oct 2025Death moderatedaily23 bars out1 bar cross test

About INVA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$13.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.